Harvard Bioscience Inc. (HBIO) PT Lowered to $0.60 at Benchmark After Q4 Results
Tweet Send to a Friend
Benchmark analyst Bruce Jackson lowered the price target on Harvard Bioscience Inc. (NASDAQ: HBIO) to $0.60 (from $2.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
